We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Researchers Create Menagerie of Biocompatible Micromachines

By LabMedica International staff writers
Posted on 18 Feb 2019
A team of Swiss biotech engineers has demonstrated possible medical applications for biocompatible micromachines constructed from gold nanorods coated with a thermoresponsive polymer.

Investigators at École Polytechnique Fédérale de Lausanne (Switzerland) combined several advanced techniques including programmable colloidal self-assembly, light-harvesting with plasmonic nanotransducers, and in situ polymerization of compliant hydrogel mechanisms to build biologically inspired, soft microelectromechanical systems (MEMS) devices. More...
These optomechanical microactuators were synthesized using a template-assisted microfluidic approach in which gold nanorods coated with a thermoresponsive polymer functioned as nanoscale building blocks.

The investigators reported in the February 4, 2019, online edition of the journal Lab on a Chip that near-infrared (NIR) laser illumination provided effective control over actuation of the resulting microactuators. These micromachines exhibited mechanical properties and performance characteristics that were comparable to those of bioengineered muscular constructs.

The investigators demonstrated the versatility of this approach by manufacturing a diverse array of microdevices including lever arms, continuum microrobots, and dexterous microgrippers.

"We wanted to create a modular system powered by the contraction of distributed actuators and the deformation of compliant mechanisms," said senior author Dr. Selman Sakar, an assistant professor in the institute of mechanical engineering at École Polytechnique Fédérale de Lausanne.

Related Links:
École Polytechnique Fédérale de Lausanne


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
UHF RFID Tag & Inlay
AD-327 U9 ETSI Pure 95
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Switching to an experimental drug after liquid biopsy detection of breast cancer recurrence can improve outcomes (Photo courtesy of Shutterstock)

Treatment Switching Guided by Liquid Biopsy Blood Tests Improves Outcomes for Breast Cancer Patients

Standard treatment for patients with advanced estrogen receptor (ER)-positive, HER2-negative breast cancer, a subtype driven by estrogen receptors that fuel tumor growth, often involves aromatase inhibitors,... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.